Jefferies Group LLC Set Hold Rating for Teleflex Incorporated (TFX)

Jefferies Group LLC Set Hold Rating for Teleflex Incorporated (TFX)

Teleflex Incorporated (NYSE:TFX)‘s stock had its “hold” rating reissued by research analysts at Jefferies Group LLC in a note issued to investors on Monday.

A number of other research analysts have also recently issued reports on the stock. Deutsche Bank AG lifted their price target on shares of Teleflex from $192.00 to $213.00 and gave the company a “buy” rating in a research report on Wednesday, March 15th. Zacks Investment Research raised shares of Teleflex from a “hold” rating to a “buy” rating and set a $217.00 price target for the company in a research report on Tuesday, March 14th. Needham & Company LLC began coverage on shares of Teleflex in a research report on Monday, March 6th. They set a “buy” rating and a $221.00 price target for the company. Barclays PLC reissued a “buy” rating and set a $205.00 price target on shares of Teleflex in a research report on Wednesday, March 1st. Finally, Stephens raised shares of Teleflex from an “equal weight” rating to an “overweight” rating in a research report on Friday, February 24th. Two equities research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. Teleflex currently has an average rating of “Buy” and a consensus target price of $200.86.

Teleflex (NYSE:TFX) opened at 194.87 on Monday. The stock has a market capitalization of $8.75 billion, a PE ratio of 39.10 and a beta of 0.93. The firm has a 50-day moving average of $186.97 and a 200-day moving average of $167.94. Teleflex has a 1-year low of $136.53 and a 1-year high of $198.89.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, February 23rd. The medical technology company reported $2.13 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.09 by $0.04. Teleflex had a net margin of 15.09% and a return on equity of 15.66%. The company earned $513.90 million during the quarter, compared to analysts’ expectations of $502.64 million. During the same period last year, the company posted $2.01 EPS. Teleflex’s revenue was up 6.1% on a year-over-year basis. Equities analysts expect that Teleflex will post $8.10 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, March 15th. Shareholders of record on Friday, March 3rd were paid a dividend of $0.34 per share. The ex-dividend date was Wednesday, March 1st. This represents a $1.36 dividend on an annualized basis and a yield of 0.70%. Teleflex’s dividend payout ratio is currently 23.49%.

A number of hedge funds have recently added to or reduced their stakes in the stock. Price T Rowe Associates Inc. MD raised its stake in Teleflex by 0.9% in the third quarter. Price T Rowe Associates Inc. MD now owns 4,856,601 shares of the medical technology company’s stock worth $816,152,000 after buying an additional 42,996 shares in the last quarter. Janus Capital Management LLC raised its stake in Teleflex by 36.6% in the fourth quarter. Janus Capital Management LLC now owns 2,764,584 shares of the medical technology company’s stock worth $445,520,000 after buying an additional 740,932 shares in the last quarter. Atlanta Capital Management Co. L L C raised its stake in Teleflex by 25.4% in the fourth quarter. Atlanta Capital Management Co. L L C now owns 2,440,831 shares of the medical technology company’s stock worth $393,340,000 after buying an additional 494,170 shares in the last quarter. State Street Corp raised its stake in Teleflex by 14.9% in the fourth quarter. State Street Corp now owns 1,332,507 shares of the medical technology company’s stock worth $214,718,000 after buying an additional 172,780 shares in the last quarter. Finally, BlackRock Institutional Trust Company N.A. raised its stake in Teleflex by 1.2% in the third quarter. BlackRock Institutional Trust Company N.A. now owns 1,297,977 shares of the medical technology company’s stock worth $218,125,000 after buying an additional 15,233 shares in the last quarter. Institutional investors and hedge funds own 93.02% of the company’s stock.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Related posts

Leave a Comment